Retatrutide and trizepatide are a novel class of medications that act on both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These dual receptor agonists exhibit https://zoeitpf229079.webdesign96.com/39045480/novel-glp-1-and-gip-receptor-agonists-retatrutide-and-trizepatide